PTCT Q1 2020 Earnings — PTC Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

PTCTPTC Therapeutics, Inc.

$5B

Q1 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$68M+27.4% YoY

Gross Profit

$64M94.0% margin

Operating Income

-$93M-136.2% margin

Net Income

-$113M-165.1% margin

EPS (Diluted)

$-1.81

QoQ Revenue Growth

-29.2%

Cash Flow

Operating Cash Flow

-$82M

Free Cash Flow

-$99M

Stock-Based Comp.

$15M

Balance Sheet

Total Assets

$1.5B

Total Liabilities

$1.0B

Stockholders' Equity

$529M

Cash & Equivalents

$123M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$68M	$54M	+27.4%
Gross Profit	$64M	$51M	+25.3%
Operating Income	-$93M	-$69M	-34.5%
Net Income	-$113M	-$72M	-56.3%

Revenue Segments

Product

$68M100%

Grant And Collaboration

$63,0000%